Healthy Living/WellnessCRISPR/Cas Firm Intellia Files IPO, Announces $125 Million Deal With Regeneron CRISPR firm Intellia Therapeutics filed an IPO and announced its collaboration with biopharmaceutical company Regeneron. The deal between the two companies aims to develop CRISPR/Cas technology and commercialize targets along the way.by Rina Marie Doctor
Healthy Living/WellnessNew Study Links Hormone Therapy For Prostate Cancer To Depressionby Ted Ranosa
Healthy Living/WellnessChinese Scientists Edit Genes Of Human Embryos For The Second Timeby Katrina Pascual
Healthy Living/WellnessGenetic Superheroes: Scientists Find 13 Rare Individuals Resistant To Hereditary Diseasesby Rhodi Lee
Healthy Living/WellnessDARPA Wants Shape-Shifting Vaccines That Adapt Real-Time When Fighting Killer Viruses: Here's The Planby Milafel Dacanay
Healthy Living/WellnessFitbit Tracker Likely Saved This Man's Life, Leading Doctors To Shock His Heart Back To Normalby Alexandra Burlacu
Biohacking Explained: Essential Wellness Safe Practices and Health Tips for Optimizing Your Body and Mind